Triple-Negative Breast Cancer: Genetic Vulnerabilities and Emerging Targets for Precision Oncology

Topic Information

Dear Colleagues,

Triple-negative breast Cancer (TNBC) is a highly aggressive and heterogeneous subtype of breast cancer characterized by the absence of estrogen and progesterone receptors and HER2 amplification. This biological profile is associated with poor prognosis, high recurrence rates, and limited therapeutic options. Recent advances in large-scale techniques, like genomics, epigenomics, transcriptomics, and tumor immunology knowledge, have uncovered multiple genetic vulnerabilities and molecular mechanisms that drive TNBC progression and resistance to therapy. In parallel, emerging precision oncology strategies include immune checkpoint inhibitors and novel targeted agents, which have shown promising results in some patients, supporting the importance of personalized approaches in TNBC treatment. This Topic aims to compile original research, comprehensive reviews, and case studies focused on the biological mechanisms and clinical management strategies of TNBC. The scope includes the following: Genetic and epigenetic alterations in TNBC Identification and validation of novel biomarkers; Multi-omics integration and subtype classification; Mechanisms of therapeutic resistance; Immune microenvironment and immunotherapy; Novel drug targets and preclinical models; Population-based studies and Disparities in TNBC outcomes. We welcome multidisciplinary contributions from molecular biology, bioinformatics, pharmacology, oncology, pathology, and public health to foster collaboration and innovation in tackling TNBC's unique challenges.

Dr. Tatiana de Almeida Simão
Dr. Sheila Coelho Soares-Lima
Topic Editors

Keywords

Participating Journals

Journal Name	Impact Factor	CiteScore	Launched Year	First Decision (median)	APC
Cancers cancers	4.4	8.8	2009	17.4 Days	CHF 2900	Submit
Diagnostics diagnostics	3.3	5.9	2011	20.3 Days	CHF 2600	Submit
Journal of Clinical Medicine jcm	2.9	5.2	2012	16 Days	CHF 2600	Submit
Life life	3.4	6.0	2011	17.8 Days	CHF 2600	Submit
Medical Sciences medsci	4.4	8.7	2013	24 Days	CHF 1400	Submit

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers